Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GLIOBLASTOMA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GLIOBLASTOMA is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, ALZHEIMER'S DISEASE, Aging. Connected to 605 entities in the SciDEX knowledge graph.
| Gene Symbol | GLIOBLASTOMA |
| Associated Diseases | ALS, Aging, Alzheimer, Breast Cancer, Cancer |
| Known Drugs/Compounds | TEMOZOLOMIDE |
| Interactions | C3AR1, ASTROCYTE, FN1, ANXA2, DGAT1, CANCER |
| KG Connections | 1361 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| MITOCHONDRIA["MITOCHONDRIA"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| Tumor["Tumor"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"associated"| Glioblastoma["Glioblastoma"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"activates"| Cancer["Cancer"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"expressed in"| Parkinson["Parkinson"]
GLIOBLASTOMA["GLIOBLASTOMA"] -->|"expressed in"| Glioblastoma_1["Glioblastoma"]
PI3K_AKT_MTOR_PATHWAY["PI3K_AKT_MTOR_PATHWAY"] -->|"activates"| GLIOBLASTOMA["GLIOBLASTOMA"]
MTOR["MTOR"] -->|"activates"| GLIOBLASTOMA["GLIOBLASTOMA"]
AUTOPHAGY["AUTOPHAGY"] -->|"co discussed"| GLIOBLASTOMA["GLIOBLASTOMA"]
ALZHEIMER["ALZHEIMER"] -->|"co discussed"| GLIOBLASTOMA["GLIOBLASTOMA"]
style GLIOBLASTOMA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | associated_with | disease | 1.00 |
| Glioblastoma | associated_with | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Glioblastoma | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Glioblastoma | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| Glioblastoma | inhibits | disease | 1.00 |
| Glioblastoma | regulates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Glioma | associated_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Glioma | activates | disease | 1.00 |
| lipid metabolism | activates | process | 0.90 |
| Mtor | activates | pathway | 0.90 |
| MTOR | activates | gene | 0.90 |
| Autophagy | activates | pathway | 0.90 |
| Als | associated_with | disease | 0.85 |
| Cancer | associated_with | disease | 0.85 |
| Als | regulates | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| Glioma | therapeutic_target | disease | 0.85 |
| Glioma | regulates | disease | 0.85 |
| Glioblastoma | treats | disease | 0.85 |
| Tumor | treats | disease | 0.85 |
| Mtor | therapeutic_target | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.80 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.80 |
| Invasion | activates | pathway | 0.80 |
| Invasion | regulates | pathway | 0.80 |
| CANCER | therapeutic_target | gene | 0.80 |
| Wnt | activates | pathway | 0.80 |
| Pi3K/Akt | therapeutic_target | pathway | 0.80 |
| Glioblastoma | expressed_in | disease | 0.75 |
| Cancer | expressed_in | disease | 0.75 |
| Aging | therapeutic_target | disease | 0.75 |
| Cancer | implicated_in | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Tumor | interacts_with | disease | 0.75 |
| Als | treats | disease | 0.75 |
| Glioblastoma | implicated_in | disease | 0.75 |
| Glioblastoma | causes | disease | 0.75 |
| Lipid Metabolism | associated_with | pathway | 0.70 |
| Pi3K/Akt | activates | pathway | 0.70 |
| Angiogenesis | activates | pathway | 0.70 |
| CANCER | activates | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GBM | associated_with | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| GBM | therapeutic_target | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| EGFR | activates | gene | 1.00 |
| IDH1 | associated_with | entity | 0.98 |
| AKT | associated_with | gene | 0.90 |
| MTOR | associated_with | gene | 0.90 |
| SREBP1 | associated_with | entity | 0.90 |
| DGAT1 | associated_with | entity | 0.90 |
| SOAT1 | associated_with | entity | 0.90 |
| CYP46A1 | downregulates | gene | 0.90 |
| PI3K | therapeutic_target | gene | 0.90 |
| GBM | activates | gene | 0.90 |
| AUTOPHAGY | activates | gene | 0.90 |
| MICROGLIA | associated_with | gene | 0.82 |
| EGFR | associated_with | gene | 0.82 |
| PARKINSON'S DISEASE | associated_with | disease | 0.82 |
| PI3K | associated_with | gene | 0.82 |
| SMPD1 | biomarker_for | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| GBM | expressed_in | gene | 0.80 |
| APOPTOSIS | activates | gene | 0.80 |
| TP53 | regulates | gene | 0.80 |
| EGFR | inhibits | gene | 0.80 |
| NEURODEGENERATION | activates | gene | 0.80 |
| AKT | therapeutic_target | gene | 0.80 |
| NF-KB | associated_with | protein | 0.74 |
| GENES | therapeutic_target | gene | 0.70 |
| CANCER | expressed_in | gene | 0.70 |
| EGFR | therapeutic_target | gene | 0.70 |
| NF-ΚB | therapeutic_target | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| GENES | regulates | gene | 0.70 |
| PHAGOCYTOSIS | therapeutic_target | gene | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| FN1 | activates | gene | 0.70 |
| GBM | regulates | gene | 0.70 |
| GBM | implicated_in | gene | 0.70 |
| CANCER | implicated_in | gene | 0.70 |
| GAIN | activates | gene | 0.70 |
| APOPTOSIS | inhibits | gene | 0.70 |
| DNA | treats | gene | 0.70 |
| DNA | therapeutic_target | gene | 0.70 |
| OVERVIEW | therapeutic_target | gene | 0.70 |
| STAT3 | therapeutic_target | gene | 0.70 |
| GBM | treats | gene | 0.70 |
| APOPTOSIS | associated_with | gene | 0.66 |
| EPILEPSY | regulates | disease | 0.65 |
| CHOLINERGIC | causes | cell_type | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neuro-oncology | 2026-04-13 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||